AlloVir, Inc. (ALVR)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
David Hallal
Employees:
21
2925 RICHMOND AVE., SUITE 1274, HOUSTON, TX 77098
651-628-9259

We are a leading late clinical-stage cell therapy company developing highly innovative allogeneic T cell therapies to treat and prevent devastating viral diseases. Our innovative and proprietary virus-specific T cell, or VST, therapy platform allows us to generate off-the-shelf VSTs designed to restore immunity in patients with T cell deficiencies who are at risk from the life-threatening consequences of viral diseases.

Data derived from most recent annual or quarterly report
Market Cap 300.589 Million Shares Outstanding65.346 Million Avg 30-day Volume 5.091 Million
P/E Ratio0.0 Dividend Yield0.0 EPS-1.1
Price to Revenue0.0 Debt to Equity0.0 EBITDA-170.884 Million
Price to Book Value3.7537 Operating Margin0.0 Enterprise Value596.599 Million
Current Ratio6.693 EPS Growth-0.058 Quick Ratio6.556
1 Yr BETA 1.9513 52-week High/Low 26.41 / 3.21 Profit Margin0.0
Operating Cash Flow Growth-74.8351 Altman Z-Score5.7401 Free Cash Flow to Firm -98.427 Million
Earnings Report2022-08-05
View SEC Filings from ALVR instead.

View recent insider trading info

Funds Holding ALVR (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ALVR BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

5 Thousand total shares from 1 transactions

Open Market Sells (S)

23.8 Thousand total shares from 7 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

VAN BEEK JEROEN B CHIEF COMMERCIAL OFFICER

  • Officer
389,526 2022-05-17 9

BORNSTEIN JEFFREY S

  • Director
40,197 2022-04-26 3

HALLAL DAVID

  • Director
  • 10% Owner
17,423,702 2022-04-21 4

SINHA VIKAS SEE REMARKS

  • Officer
  • Director
14,327,603 2022-04-20 3

HAGEN BRETT R CHIEF ACCOUNTING OFFICER

  • Officer
80,368 2022-04-20 3

ATILLASOY ERCEM SEE REMARKS

  • Officer
121,563 2022-04-20 4

TOMASELLO SHAWN

  • Director
0 2022-03-29 2

MILLER EDWARD GENERAL COUNSEL

  • Officer
466,862 2022-01-18 1

BRAINARD DIANA CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
1,106,300 2022-01-18 1

LEEN ANN M. CHIEF SCIENTIFIC OFFICER

  • Officer
2,316,154 2021-11-12 1

JOVAN-EMBIRICOS MORANA

  • Director
18,380,807 2021-11-10 5

MELIAN AGUSTIN CHIEF MEDICAL OFFICER

  • Officer
453,529 2021-10-04 2

GADICKE ANSBERT

  • Director
  • 10% Owner
22,500 2021-05-25 1

VERA JUAN

  • Director
22,500 2021-05-25 1

WILSON JOHN ROBERT

  • Director
5,385,453 2021-05-25 1

BRENNER MALCOLM

  • Director
186,232 2021-05-25 1

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

VAN BEEK JEROEN B - Officer CHIEF COMMERCIAL OFFICER

2022-05-18 08:57:20 -0400 2022-05-17 S 15,262 $4.40 d 389,526 direct

BORNSTEIN JEFFREY S - Director

2022-04-28 07:46:49 -0400 2022-04-26 P 5,000 $4.64 a 40,197 direct -5.6017 2.0747 2.6971 5 -5.6017 2

ATILLASOY ERCEM - Officer SEE REMARKS

2022-04-22 08:23:31 -0400 2022-04-21 S 1,587 $5.86 d 121,563 direct 9.5133 0.6637 9.5133 2 -0.885 4

HALLAL DAVID - Director - > 10% Owner

2022-04-22 08:31:45 -0400 2022-04-21 S 4,227 $5.87 d 2,143,614 direct yes 9.5133 0.6637 9.5133 2 -0.885 4

ATILLASOY ERCEM - Officer SEE REMARKS

2022-04-22 08:23:31 -0400 2022-04-20 S 453 $6.68 d 123,150 direct 9.5133 0.6637 9.5133 2 -0.885 4

SINHA VIKAS - Director - Officer SEE REMARKS

2022-04-22 08:29:58 -0400 2022-04-20 S 1,162 $6.68 d 906,633 direct 9.5133 0.6637 9.5133 2 -0.885 4

HAGEN BRETT R - Officer CHIEF ACCOUNTING OFFICER

2022-04-22 08:20:28 -0400 2022-04-20 S 276 $6.68 d 80,368 direct 9.5133 0.6637 9.5133 2 -0.885 4

VAN BEEK JEROEN B - Officer CHIEF COMMERCIAL OFFICER

2022-04-22 08:28:39 -0400 2022-04-20 S 852 $6.68 d 404,788 direct 9.5133 0.6637 9.5133 2 -0.885 4

TOMASELLO SHAWN - Director

2022-03-31 17:20:13 -0400 2022-03-29 A 45,000 a 45,000 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
ALLOVIR INC ALVR 2022-05-18 22:15:03 UTC -0.2273 1.0473 75000
ALLOVIR INC ALVR 2022-05-18 21:45:03 UTC -0.2322 1.0522 75000
ALLOVIR INC ALVR 2022-05-18 21:15:04 UTC -0.2322 1.0522 75000
ALLOVIR INC ALVR 2022-05-18 20:45:03 UTC -0.2328 1.0528 75000
ALLOVIR INC ALVR 2022-05-18 20:15:05 UTC -0.2328 1.0528 75000
ALLOVIR INC ALVR 2022-05-18 19:45:03 UTC -0.2328 1.0528 75000
ALLOVIR INC ALVR 2022-05-18 19:15:03 UTC -0.2328 1.0528 75000
ALLOVIR INC ALVR 2022-05-18 18:45:03 UTC -0.2321 1.0521 75000
ALLOVIR INC ALVR 2022-05-18 18:15:03 UTC -0.2321 1.0521 75000
ALLOVIR INC ALVR 2022-05-18 17:45:03 UTC -0.2321 1.0521 75000
ALLOVIR INC ALVR 2022-05-18 17:15:03 UTC -0.2321 1.0521 75000
ALLOVIR INC ALVR 2022-05-18 16:45:03 UTC -0.2524 1.0724 75000
ALLOVIR INC ALVR 2022-05-18 16:15:03 UTC -0.2524 1.0724 75000
ALLOVIR INC ALVR 2022-05-18 15:45:03 UTC -0.2524 1.0724 75000
ALLOVIR INC ALVR 2022-05-18 15:15:03 UTC -0.2524 1.0724 75000
ALLOVIR INC ALVR 2022-05-18 14:45:03 UTC -0.2003 1.0203 75000
ALLOVIR INC ALVR 2022-05-18 14:15:04 UTC -0.2003 1.0203 70000
ALLOVIR INC ALVR 2022-05-18 13:45:03 UTC -0.2003 1.0203 70000
ALLOVIR INC ALVR 2022-05-18 13:15:03 UTC -0.2003 1.0203 70000
ALLOVIR INC ALVR 2022-05-18 12:45:03 UTC -0.2003 1.0203 70000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
RUSSELL INVESTMENT FUNDS- U.S. Small Cap Equity Fund ALVR -139.0 shares, $-1798.66 2021-12-31 N-PORT

Elevate your investments